ReFLECT: Relationships Among Cognitive Function, Lifestyle, and Exercise After Cancer Treatment

Sponsor
University of Illinois at Urbana-Champaign (Other)
Overall Status
Completed
CT.gov ID
NCT02523677
Collaborator
(none)
456
1
25
18.2

Study Details

Study Description

Brief Summary

The purpose of this study is to examine relationships among lifestyle behaviors (i.e., physical activity, sleep), cognitive function (i.e., memory, processing speed, and executive function), and quality of life in breast cancer patients and survivors across time. The investigators will compare the strength of these relationships across age cohorts and time since treatment and diagnosis. Participants will complete a battery of questionnaires and a set of cognitive tests on an iPad app specifically tailored for this study. A subset of participants will also wear an accelerometer for seven days. Data will be collected at baseline and 6-month follow-up.

This research is critical to identifying potentially important approaches to improving health outcomes and quality of life in breast cancer patients and survivors. Previous research provides evidence of the influence of lifestyle behaviors on cognition and quality of life in healthy aging populations. However, despite data indicating cancer's negative impact on lifestyle behaviors, cognition, and quality of life, very few studies have investigated interactions among these factors in cancer patients and survivors.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Interested individuals will visit the ReFLECT Study website (www.reflectstudies.org) to learn more about the study and receive instructions on how to participate. Individuals will be instructed to create a username (email address) and password for BrainBaseline© (www.BrainBaseline.com; Digital Artefacts, Iowa City, IA). While BrainBaseline© is a commercially available mobile app, a version specifically tailored for this study will be used. The website directions will include information on how to download the BrainBaseline© iPad app (for ReFLECT) from the iTunes store. Each time a participant closes and reopens the iPad app, she will be required to enter her BrainBaseline© username and password. Upon opening the iPad app for the first time, the individual will be asked to confirm their eligibility for the study. If eligible, the individual will proceed to the consent form. Participants will electronically sign the Institutional Review Board-approved informed consent form before completing a battery of questionnaires assessing demographics, medical history, physical activity, sedentary behavior, sleep, fatigue, quality of life, satisfaction with life, depressive symptoms, and perceived memory. Individuals cannot view the questionnaires until they have electronically signed the consent form. Participants will also be asked to complete a set of ten evidence-based cognitive tests assessing attention, speed of processing, and executive function. Descriptions of the tests are available at www.BrainBaseline.com/assessments. The questionnaires are expected to take approximately 45 minutes and the cognitive tests are expected to take approximately 60 minutes to complete. Participants will be instructed to complete the questionnaires and cognitive tests within two weeks of signing the consent form. The onscreen instructions and consent form will also notify participants that a) they do not have to complete either the questionnaires or the cognitive tests in one sitting, but can return to them during the course of the week, and b) they can move back and forth between the questionnaires and cognitive tests (i.e., do not need to finish one section before moving to the next). Reminder emails will be sent on days 7 and 10 to remind participants to complete assessments.

    A subset of participants who volunteer to do so will also wear an accelerometer for 24 hours per day for 7 consecutive days to objectively measure activity levels and sleep quality. Individuals will be asked if they are willing to be contacted to wear the accelerometer via the consent form. Only those individuals who check the box agreeing to be contacted by the research team will be contacted to wear the accelerometer (see consent form). Participants will be contacted via email and instructed to reply to the researcher by phone or email with their mailing address. The accelerometer, instructions for wear, a Record of Use form, and a postage-paid return envelope will be mailed to participants who agree to wear the monitor. Mailing labels from postage-paid return envelopes will be disposed of after accelerometers have been returned and recorded. The accelerometer will be worn during women's daily life on a normal week; therefore, minimal additional time committed to research activities will be required of participants. No contact will be solicited with participants over the course of the 6-month study period.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    456 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Relationships Among Cognitive Function, Lifestyle, and Exercise After Cancer Treatment
    Study Start Date :
    Jul 1, 2015
    Actual Primary Completion Date :
    Jul 31, 2017
    Actual Study Completion Date :
    Jul 31, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Change in Executive Function [Baseline, 6 months]

      Executive Function will be expressed as a composite score of the following cognitive tests: Flanker, Task-Switch, Trails A&B, Mazes

    2. Change in Working Memory [Baseline, 6 months]

      Working Memory will be expressed as a composite score of the following cognitive tests: N-Back, Spatial Working Memory, Spatial Span, and Swap

    3. Change in Speed of Processing [Baseline, 6 months]

      Speed of Processing will be expressed as a composite score of the following cognitive tests: Digital Symbols Substitution, Flanker, Speed, Task-Switch, and Trails A&B

    Secondary Outcome Measures

    1. Medical Health History [Baseline, 6 months]

      Medical health history will be measured at baseline and 6-month follow-up to identify any changes to participants' health status during the study period. If no changes are observed, baseline values may be used as covariates or moderators in data analyses.

    2. Change in Sleep Quality (objectively measured) [Baseline, 6 months]

      Change in sleep quality as measured by a wrist-worn accelerometer will be examined as a predictor of change in executive function, working memory, and speed of processing.

    3. Change in Physical Activity (objectively measured) [Baseline, 6 months]

      Change in physical activity as measured by a waist-worn accelerometer will be examined as a predictor of change in executive function, working memory, and speed of processing.

    Other Outcome Measures

    1. Change in Sleep Quality (self-report) [Baseline, 6 months]

      Change in sleep quality as measured by the Pittsburgh Sleep Quality Index will be examined as a predictor of change in executive function, working memory, and speed of processing.

    2. Change in Physical Activity (self-report) [Baseline, 6 months]

      Change in physical activity as measured by the Godin Leisure-Time Exercise Questionnaire will be examined as a predictor of change in executive function, working memory, and speed of processing.

    3. Change in Sitting Time [Baseline, 6 months]

      Change in sitting time as measured by the Sitting Time Questionnaire will be examined as a predictor of change in executive function, working memory, and speed of processing.

    4. Change in Sedentary Activity [Baseline, 6 months]

      Change in sedentary activity as measured by the Longitudinal Aging Study Amsterdam Sedentary Behavior Questionnaire will be examined as a predictor of change in executive function, working memory, and speed of processing.

    5. Change in Current Symptoms [Baseline, 6 months]

      Change in breast cancer related symptoms as measured by the Functional Assessment of Cancer Therapy - Breast will be examined as a potential confounder or moderator of the relationship between physical activity and cognitive function.

    6. Change in Fatigue [Baseline, 6 months]

      Change in fatigue as measured by the Functional Assessment of Chronic Illness Therapy 13-Item Fatigue Scale will be examined as a potential confounder or moderator of the relationship between physical activity and cognitive function.

    7. Change in Anxiety and Depression [Baseline, 6 months]

      Change in anxiety and depression as measured by the Hospital Anxiety and Depression Scale will be examined as potential confounders or moderators of the relationship between physical activity and cognitive function.

    8. Change in Quality of Life [Baseline, 6 months]

      Relationships between change in physical activity and cognitive function and change in quality of life as measured by the Satisfaction with Life Scale will be examined.

    9. Change in Memory [Baseline, 6 months]

      Change in memory as measured by the Memory Controllability Inventory will be examined as an outcome of changes in sleep quality and physical activity.

    10. Change in Forgetfulness [Baseline, 6 months]

      Change in forgetfulness as measured by the Frequency of Forgetting Questionnaire will be examined as an outcome of changes in sleep quality and physical activity.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Female diagnosed with breast cancer

    • 21 years or older

    • English speaking

    • Access to an iPad with iOS 6.2 or later and the Internet

    Exclusion Criteria:
    • Male

    • Individuals under 21 years of age

    • Individuals who do not have access to an iPad with iOS 6.2 or later

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Illinois at Urbana-Champaign Urbana Illinois United States 61801

    Sponsors and Collaborators

    • University of Illinois at Urbana-Champaign

    Investigators

    • Principal Investigator: Edward McAuley, PhD, University of Illinois Urbana-Champaign

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Edward McAuley, Shahid and Ann Carlson Khan Professor in Applied Health Sciences, University of Illinois at Urbana-Champaign
    ClinicalTrials.gov Identifier:
    NCT02523677
    Other Study ID Numbers:
    • UIUC_IRB_15666
    First Posted:
    Aug 14, 2015
    Last Update Posted:
    Oct 6, 2017
    Last Verified:
    Oct 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 6, 2017